CN103582818B - 戈谢病的诊断方法 - Google Patents

戈谢病的诊断方法 Download PDF

Info

Publication number
CN103582818B
CN103582818B CN201280027860.3A CN201280027860A CN103582818B CN 103582818 B CN103582818 B CN 103582818B CN 201280027860 A CN201280027860 A CN 201280027860A CN 103582818 B CN103582818 B CN 103582818B
Authority
CN
China
Prior art keywords
biomarker
subject
sample
level
gaucher disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201280027860.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN103582818A (zh
Inventor
阿恩特·罗尔夫斯
赫尔曼·马舍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro Gene Co ltd
Original Assignee
Centogene GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44652046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN103582818(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centogene GmbH filed Critical Centogene GmbH
Publication of CN103582818A publication Critical patent/CN103582818A/zh
Application granted granted Critical
Publication of CN103582818B publication Critical patent/CN103582818B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442—Chitinase (3.2.1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids
    • G01N2405/10—Glycosphingolipids, e.g. cerebrosides, gangliosides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CN201280027860.3A 2011-06-06 2012-06-06 戈谢病的诊断方法 Expired - Fee Related CN103582818B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11004597A EP2533051A1 (en) 2011-06-06 2011-06-06 Method for the diagnosis of Gaucher's disease
EP11004597.8 2011-06-06
PCT/EP2012/002409 WO2012167925A1 (en) 2011-06-06 2012-06-06 Method for the diagnosis of gaucher's disease

Publications (2)

Publication Number Publication Date
CN103582818A CN103582818A (zh) 2014-02-12
CN103582818B true CN103582818B (zh) 2018-06-05

Family

ID=44652046

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280027860.3A Expired - Fee Related CN103582818B (zh) 2011-06-06 2012-06-06 戈谢病的诊断方法

Country Status (15)

Country Link
US (3) US10859580B2 (enExample)
EP (4) EP2533051A1 (enExample)
JP (2) JP6120832B2 (enExample)
CN (1) CN103582818B (enExample)
AU (2) AU2012266768B2 (enExample)
BR (1) BR112013031431B1 (enExample)
CA (1) CA2837609C (enExample)
DK (2) DK3318881T3 (enExample)
ES (2) ES2820361T3 (enExample)
IL (2) IL229607B (enExample)
NO (1) NO2718725T3 (enExample)
PL (2) PL3318881T3 (enExample)
PT (2) PT3318881T (enExample)
RU (1) RU2666952C2 (enExample)
WO (1) WO2012167925A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015007494A (es) * 2012-12-11 2015-12-15 Centogene Ag Metodo para diagnosticar leucodistrofia metacromatica.
WO2015121855A1 (en) * 2014-02-11 2015-08-20 Yeda Research And Development Co. Ltd. Marker of neuropathic gaucher's disease and methods of use thereof
CN105463085A (zh) * 2015-12-11 2016-04-06 上海新培晶医学检验所有限公司 一种检测戈谢病gba基因突变的试剂盒及其检测方法
EP3264092A1 (en) * 2016-07-01 2018-01-03 Centogene AG Use of lyso-gb1 as druggable target
RU2629626C1 (ru) * 2016-10-05 2017-08-30 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ оценки эффективности лечения болезни Гоше у детей
CA3201604A1 (en) 2020-12-08 2022-06-16 Todd Frank OVOKAITYS Methods and systems for increased production of stem cells
IL317112A (en) * 2022-06-01 2025-01-01 Univ Antwerpen Method for detecting biomarkers of lysosomal storage disease and kits for performing the method
WO2024211616A1 (en) * 2023-04-04 2024-10-10 Ovokaitys Todd Frank Methods and systems for improved therapies of genetic diseases using photo-activated allogenic stem cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236838A (en) 1988-12-23 1993-08-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
UA63743A (en) * 2003-06-09 2004-01-15 Kyiv P Shupyk Medical Academy Method for diagnosing gaucher disease
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
ES2485369T3 (es) 2005-06-08 2014-08-13 Amicus Therapeutics, Inc. Tratamiento de trastornos del SNC asociados con mutaciones en genes que codifican enzimas lisosómicas
DK2040548T3 (da) * 2006-06-23 2012-08-13 Amicus Therapeutics Inc Fremgangsmåde til behandling af neurologiske forstyrrelser ved forøgelse af aktiviteten af beta-glucocerebrosidase
MX2009011055A (es) 2007-04-13 2010-01-13 Amicus Therapeutics Inc Tratamiento de la enfermedad de gaucher con chaperonas farmacologicas especificas y supervision del tratamiento utilizando marcadores sustitutos.
AU2008245578A1 (en) 2007-04-26 2008-11-06 Amicus Therapeutics, Inc. Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
CN104383556B (zh) * 2007-05-16 2018-06-05 布里格姆妇女医院 突触核蛋白病的治疗
AU2009314447A1 (en) * 2008-11-14 2010-05-20 Neuraltus Pharmaceuticals, Inc. Compositions and methods for the treatment of altered alpha-synuclein function

Also Published As

Publication number Publication date
RU2018129872A3 (enExample) 2021-11-08
IL260078A (en) 2018-07-31
EP3742168A1 (en) 2020-11-25
CN103582818A (zh) 2014-02-12
JP6120832B2 (ja) 2017-04-26
IL229607A0 (en) 2014-01-30
BR112013031431A2 (pt) 2016-12-13
RU2013158667A (ru) 2015-07-20
AU2017232226B2 (en) 2019-12-19
US20140187439A1 (en) 2014-07-03
US20180259538A1 (en) 2018-09-13
PT2718725T (pt) 2018-03-07
PL3318881T3 (pl) 2021-02-08
RU2666952C2 (ru) 2018-09-13
NO2718725T3 (enExample) 2018-05-12
ES2659753T3 (es) 2018-03-19
JP2017161528A (ja) 2017-09-14
CA2837609C (en) 2023-04-18
EP2718725B1 (en) 2017-12-13
BR112013031431B1 (pt) 2023-02-07
AU2012266768B2 (en) 2017-06-29
JP2014517308A (ja) 2014-07-17
RU2018129872A (ru) 2019-03-15
PL2718725T3 (pl) 2018-06-29
IL260078B (en) 2020-10-29
DK3318881T3 (da) 2020-09-28
EP2718725A1 (en) 2014-04-16
EP3318881B1 (en) 2020-07-15
EP3318881A1 (en) 2018-05-09
AU2017232226A1 (en) 2017-10-12
US10859580B2 (en) 2020-12-08
WO2012167925A1 (en) 2012-12-13
US20220011321A1 (en) 2022-01-13
CA2837609A1 (en) 2012-12-13
IL229607B (en) 2018-07-31
PT3318881T (pt) 2020-09-16
JP6514256B2 (ja) 2019-05-15
US11092609B2 (en) 2021-08-17
DK2718725T3 (en) 2018-03-26
ES2820361T3 (es) 2021-04-20
EP2533051A1 (en) 2012-12-12

Similar Documents

Publication Publication Date Title
US11092609B2 (en) Method for the diagnosis of Gaucher's disease
US11841362B2 (en) Method for the diagnosis of Niemann-Pick disease
AU2012266768A1 (en) Method for the diagnosis of Gaucher's disease
US10302664B2 (en) Method for the diagnosis of Niemann-Pick disease
US20180348239A1 (en) Method for the Diagnosis of Niemann-Pick Disease Using a Biomarker
RU2780331C2 (ru) Способ диагностики болезни гоше
HK40033027A (en) Biomarker for gaucher's disease
EP2743700A1 (en) Method for the diagnosis of metachromatic leukodystrophy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: Rostock, Germany

Patentee after: Centro gene Co.,Ltd.

Address before: Rostock, Germany

Patentee before: CENTOGENE AG

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180605